BD Showcases Innovative Solutions at Global Health Exhibition in Riyadh
The Saudi branch of BD (Becton, Dickinson and Company) (NYSE: BDX), a prominent global medical technology company, is making a splash at the Global Health Exhibition in Riyadh, Saudi Arabia, taking place from 21-23 October, 2024. Building on its successful participation from the previous year, BD is shining a spotlight on its latest Signature ProgrammesTM centered around Patient Safety, Healthcare Worker Safety, and Healthcare Efficiency.
The BD booth (H2B-R10) is the epicenter for healthcare professionals, partners, and key stakeholders to delve into the transformative impact of the company’s cutting-edge solutions. With a key focus on enhancing healthcare outcomes, BD’s solutions cover the entire spectrum of care, from diagnostics to medication management, infection prevention, and more.
“As a dedicated partner in Saudi Arabia’s healthcare evolution, BD is thrilled to be a part of Global Health Saudi 2024 and showcase our continuous efforts to prioritize patient safety, safeguard healthcare workers, and drive operational efficiencies,” stated Omar Malabarey, Country General Manager for BD in Saudi Arabia. “We are excited to present our Signature ProgrammesTM and innovative solutions that cater to the changing needs of healthcare professionals and patients, all while investing in the Kingdom’s healthcare landscape through local presence, education, and innovation.”
In alignment with Saudi Arabia’s Vision 2030, BD remains steadfast in its commitment to the Kingdom’s healthcare system through local investments and partnerships. Following the successful establishment of its regional headquarters in Riyadh in 2023, and in support of the Kingdom’s quest to build a top-notch healthcare infrastructure, BD is further solidifying its footprint in the country by preparing to launch a Training and Education Academy in 2024. This Academy will serve as a crucial platform to enhance the expertise of healthcare professionals nationwide by offering hands-on clinical and technical training sessions, ultimately elevating patient safety and care delivery outcomes.
Alongside the unveiling of its plans for the Academy, BD will also shed light on its recent acquisition of Edward Life Sciences, a move that bolsters the company’s patient monitoring portfolio and enriches its capabilities in delivering integrated healthcare solutions in the Kingdom.
